ArticleSmall (Weinheim an der Bergstrasse, Germany)2026
Spatially Controlled Capture and Site-Resolved Analysis of Single Extracellular Vesicles.
Article in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Quantitative fluorescence analysis of single extracellular vesicles (EVs) is often complicated by heterogeneous particle loading on continuous surfaces, obscuring where and how a signal should be counted. This study presents a simple, array-based method that couples site-specific capture into optically resolvable nanowells with mask-gated image analysis to obtain unambiguous, single-site fluorescence measurements. EVs settle onto nanowell arrays, and excess particles on the inter-well surface are cleared by a PDMS translation step, resulting in the capture of single EVs in discrete nanowells and accurate detection of in-well signals that are registered to a bright-field nanowell mask. This format yields > 99% EV capture at the designed location in grids and enables the accurate detection of EVs' fluorescence signals with a low background. Compositional analysis on a single substrate accurately tracks programmed EV mixture ratios with near-unity slopes and HER2 positivity in breast cancer EVs. Finally, the patterning method is readily adapted to plasma-derived EVs, expanded to multi-channel fluorescence imaging, and applied to mixed cargos of co-patterned EVs and nanoparticles. These results establish a reliable pathway for array-based EV detection and precise manipulations of EVs and other nanoparticles.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.